全身溶栓作为COVID-19相关急性主髂动脉及下肢动脉血栓初始治疗
Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.
PubMed 文献 · Ann Vasc Surg · 2020-08-28
本文报告一例COVID-19患者继发于主动脉瘤、髂动脉及腹股沟下动脉广泛血栓形成的急性肢体缺血。初始采用全身溶栓恢复主髂动脉闭塞的通畅性,随后对腹股沟下闭塞行开放血栓清除术。
要点
- COVID-19相关血栓栓塞事件抗凝及手术干预后结局仍不佳
- 全身溶栓可作为主髂动脉闭塞的初始治疗以恢复通畅
- 腹股沟下闭塞可后续行开放血栓清除术
核心结论
- 全身溶栓作为初始治疗可恢复COVID-19相关急性主髂动脉闭塞的通畅性,后续开放血栓清除术处理腹股沟下闭塞。
研究设计与样本
- 本文为单例病例报告,描述一例COVID-19患者继发于主动脉瘤、髂动脉及腹股沟下动脉广泛血栓形成的急性肢体缺血。
主要发现
- 初始全身溶栓恢复了主髂动脉闭塞的通畅性。
- 随后对腹股沟下闭塞行开放血栓清除术。
临床怎么用
- 对于COVID-19相关急性主髂动脉及下肢动脉血栓,可考虑全身溶栓作为初始治疗以恢复主髂动脉通畅,再处理腹股沟下闭塞。
局限性
- 单例病例报告,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SARS-CoV-2 (COVID-19) patients with associated thromboembolic events have demonstrated poor outcomes despite the use of anticoagulation therapy and surgical intervention. We present a COVID-19 patient with acute limb ischemia, secondary to extensive thrombosis of an aortic aneurysm, iliac arteries, and infrainguinal arteries. Initial treatment with systemic thrombolysis, which restored patency of the aortoiliac occlusion, was followed by open thrombectomies of the infrainguinal occlusions.
来源:Ann Vasc Surg,查看原文。版权归原作者所有。
引用
- Patel P, Yu Y, Zia S, et al. Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis. Ann Vasc Surg. 2020. PMID: 32861850. doi:10.1016/j.avsg.2020.08.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。